1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.

Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: A

Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: A

  1. Behrang
    Journal of Alzheimer's Disease, Vol. Preprint, No. Preprint, Pages 1-5, 2016

    Assaf Shelef, Yorama Barak, Urib Berger, Dianna Paleacu, Shellya Tadger, Igora Plopsky, Yehuda Baruch

    -Background: Tetrahydrocannabinol (THC) is a potential treatment for Alzheimer’s disease (AD).
    -Objective: To measure efficacy and safety of medical cannabis oil (MCO) containing THC as an add-on to pharmacotherapy, in relieving behavioral and psychological symptoms of dementia (BPSD).
    -Methods: Eleven AD patients were recruited to an open label, 4 weeks, prospective trial.
    -Results: Ten patients completed the trial. Significant reduction in CGI severity score (6.5 to 5.7; p < 0.01) and NPI score were recorded (44.4 to 12.8; p < 0.01). NPI domains of significant decrease were: Delusions, agitation/aggression, irritability, apathy, and sleep and caregiver distress.
    -Conclusion: Adding MCO to AD patients’ pharmacotherapy is safe and a promising treatment option.

    Alzheimer’s disease, behavioral and psychological symptoms of dementia, cannabis, tetrahydrocannabinol

    DOI: 10.3233/JAD-150915